MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Clovis Oncology Company Profile (NASDAQ:CLVS)

Consensus Ratings for Clovis Oncology (NASDAQ:CLVS) (?)
Ratings Breakdown: 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $32.56 (94.94% upside)

Analysts' Ratings History for Clovis Oncology (NASDAQ:CLVS)
Show:
DateFirmActionRatingPrice TargetActions
5/9/2016WallachBeth CapitalLower Price TargetHold$30.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016Piper JaffrayReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/18/2016Credit SuisseInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2016MizuhoReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2016Janney Montgomery ScottReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$42.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Stifel NicolausReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Leerink SwannBoost Price TargetOutperform$104.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Goldman SachsLower Price Target$23.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Citigroup Inc.Boost Price TargetNeutral$60.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha